The prevalence of token 2 diabetes...

The prevalence of token 2 diabetes is increasing because the population is aging and becoming more obese and more sedentary. Diabetes has become the chiefly common cause of new blindness, end-stage renal disease, and lower limb amputations in the United States. Other complications of diabetes include cardiovascular disease, visitation and early mortality. Recent research has demonstrated the important part of the renin-angiotensin aldosterone order in the increased risk for hypertension and cardiovascular disease in patients with token 2 diabetes.

McFarlane and Sowers reviewed the part of aldosterone as an added risk factor to angiotensin II for cardiovascular disease in [i]role[/i]s who have diabetes. The air of type 2 diabetes is a risk factor for cardiovascular disease and also accentuates the risk brought in succession by hypertension, smoking, and dyslipidemia. Diabetic renal disease and vascular disease incite ahead concurrently in persons with prototype 2 diabetes. Albuminuria is a predictor of cardiovascular disease and attack as well as diabetic renal disease. Activation of the renin-angiotensin connected view (RAS) negatively affects the renal glomerulus as well as the vascular arrangement The relationship of RAS activation to heart failure and thump incidence and severity also has been documented. The reduction of posterity pressure in persons with exemplar 2 diabetes who use an angiotensin-converting enzyme (ACE) inhibitor significantly abridges stroke risk. Recent data point to a similar risk reduction with the use of an angiotensin-receptor blocking (ARB) agent.

Aldosterone, a steroid hormone produc in the exterior layer of the adrenal cortex, stir ups renal sodium retention and potassium los Secretion changes present itself in response to alterations of convolution status or salt intake mediated by dint of angiotensin II. Aldosterone reduces baroreflex sensitivity and enhances sympathetic activity resulting in reduc nitric oxide-mediated vasorelaxation. This ends in reduced serum potassium on a levels and an increase in left ventricular mass and cardiac output The aldosterone antagonist spironolactone change intos morbidity and mortality in patients with strict heart failure. The procoagulant properties of aldosterone with inhibition of fibrinolysis potentiate atherosclerosis. Renal glomerulus dysfunction ends from basement membrane abnormalities, nephrosclerosis, and renal fibrosis induced through aldosterone, and leads to microalbuminuria.

The authors bring to an end that aldosterone has detrimental consequences on the vasculature, cardiac tissue, renal mesangial enclosed spaces and the brain, as well as deleterious validitys on baroreflex sensitivity and the autonomic nervous body Blocking aldosterone actions may have positive cardiovascular and renal powers Further studies are needed to investigate the efficacy of ACE inhibitor/ARB combinations and aldosterone antagonists in reduction of renal and cardiovascular disease in living bodys with type 2 diabetes.

McFarlane SI, Sowers JR Aldosterone function in diabetes mellitus: forces on cardiovascular and renal disease. J Clin Endocrinol Metab February 2003;88:516-23

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group